Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trial

BACKGROUND: Natural killer (NK) cells are one of the main effector populations of immunotherapy with monoclonal antibody and cytokines, used in combination with chemotherapy to treat children with high-risk neuroblastoma on this phase II trial. However, the impact of chemoimmunotherapy on NK cell ki...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Rosa, Sahr, Natasha, Sykes, April, McCarville, Mary Beth, Federico, Sara M, Sooter, Amanda, Cullins, David, Rooney, Barbara, Janssen, William E, Talleur, Aimee C, Triplett, Brandon M, Anthony, Gwendolyn, Dyer, Michael A, Pappo, Alberto S, Leung, Wing H, Furman, Wayne L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206969/
https://www.ncbi.nlm.nih.gov/pubmed/32221013
http://dx.doi.org/10.1136/jitc-2019-000176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206969/
https://www.ncbi.nlm.nih.gov/pubmed/32221013
http://dx.doi.org/10.1136/jitc-2019-000176

Ejemplares similares